Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
The prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effec...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2021-08-01
|
| Series: | Forum of Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/fco-2021-0014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849224997830131712 |
|---|---|
| author | Azeez Taoreed Adegoke Folorunso Sharif Adeniyi Eguzozie Chinedu Adegboyega Adeleke Adedapo |
| author_facet | Azeez Taoreed Adegoke Folorunso Sharif Adeniyi Eguzozie Chinedu Adegboyega Adeleke Adedapo |
| author_sort | Azeez Taoreed Adegoke |
| collection | DOAJ |
| description | The prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effects of antidiabetic medications. |
| format | Article |
| id | doaj-art-03791bad7e5a431e9d025c5dabb14a8a |
| institution | Kabale University |
| issn | 1792-362X |
| language | English |
| publishDate | 2021-08-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Forum of Clinical Oncology |
| spelling | doaj-art-03791bad7e5a431e9d025c5dabb14a8a2025-08-25T06:11:53ZengSciendoForum of Clinical Oncology1792-362X2021-08-01121748110.2478/fco-2021-0014Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?Azeez Taoreed Adegoke0Folorunso Sharif Adeniyi1Eguzozie Chinedu2Adegboyega Adeleke Adedapo3Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital, Ibadan, NigeriaDepartment of Radiation Oncology, University College Hospital, Ibadan, NigeriaEndocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital, Ibadan, NigeriaDepartment of Clinical Pharmacology, University College Hospital, Ibadan, NigeriaThe prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effects of antidiabetic medications.https://doi.org/10.2478/fco-2021-0014antidiabetic drugsdiabetescancer |
| spellingShingle | Azeez Taoreed Adegoke Folorunso Sharif Adeniyi Eguzozie Chinedu Adegboyega Adeleke Adedapo Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? Forum of Clinical Oncology antidiabetic drugs diabetes cancer |
| title | Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? |
| title_full | Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? |
| title_fullStr | Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? |
| title_full_unstemmed | Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? |
| title_short | Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental? |
| title_sort | antidiabetic drugs and the risk of cancer beneficial neutral or detrimental |
| topic | antidiabetic drugs diabetes cancer |
| url | https://doi.org/10.2478/fco-2021-0014 |
| work_keys_str_mv | AT azeeztaoreedadegoke antidiabeticdrugsandtheriskofcancerbeneficialneutralordetrimental AT folorunsosharifadeniyi antidiabeticdrugsandtheriskofcancerbeneficialneutralordetrimental AT eguzoziechinedu antidiabeticdrugsandtheriskofcancerbeneficialneutralordetrimental AT adegboyegaadelekeadedapo antidiabeticdrugsandtheriskofcancerbeneficialneutralordetrimental |